Genistein in the presence of 17β-estradiol inhibits proliferation of ERβ breast cancer cells

Pharmacology

Volumn 84, Issue 2, 2009, Pages 68-73

  Rajah, Talitha T ^a   Du, Nga ^a   Drews, Neil ^a   Cohn, Rachel ^a  

^a DEPAUL UNIVERSITY   (United States)

Author keywords

17 Estradiol; Breast cancer; Cell proliferation; ER ; Genistein

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; PHYTOESTROGEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; BREAST TUMOR; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENISTEIN; HUMANS; PHYTOESTROGENS;

EID: 67649208574     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000226123     Document Type: Article

References (25)

1. Kurzer MS: Soy consumption for reduction of menopausal symptoms. Inflammopharmacology 2008; 16: 227-229.
2. Ingram D, Sander K, Kolybaba M, Lopez D: Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350: 990-994.
3. Branca F, Lorenzetti S: Health effects of phytoestrogens. Forum Nutr 2005; 57: 100-111.
4. Hseih CY, Santell RC, Haslam SZ, Helferich WG: Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF7) cells in vitro and in vivo. Cancer Res 1998; 58: 3833-3838.
5. Messina M, McCaskill-Stevens W, Lampe JW: Addressing the soy and breast cancer relationship: review, commentary and workshop proceedings. J Natl Cancer Inst 2006; 98: 1275-1284.
6. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA: Estrogen receptor β inhibits 17 β -estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci 2004; 101: 1566-1571.
7. Covaleda AMS, Berg H, Vervoort J, Saag P, Strom A, Gustafsson JA, Rietjens I, Murk AJ: Influence of cellular ER α /ER β ratio on the ER α -agonist induced proliferation of human T47D breast cancer cells. Toxicol Sci 2008; 105: 303-311.
8. Speirs V: The evolving role of oestrogen receptor β in clinical breast cancer. Breast Cancer Res 2008; 10: 111.
9. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138: 863-870.
10. McCarty MF: Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses 2006; 66: 1093-1114.
11. Cappelletti V, Miodini P, DiFronzo G, Daidone MG: Modulation of estrogen receptor- β isoforms by phytoestrogens in breast cancer cells. Int J Oncol 2006; 28: 1185-1191.
12. Tong D, Schuster E, Seifert M, Czerwenka K, Leodolter S, Zeillinger R: Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines. Breast Cancer Res Treat 2002; 71: 249-255.
13. Girault I, Andrieu C, Tozlu S, Spyratos F, Bieche I, Lidereau R: Altered pattern of alternatively spliced estrogen receptor β transcripts in breast carcinoma. Cancer Lett 2004; 215: 101-112.
14. Li Z, Li J, Mo B, Hu C, Liu H, Qi H, Wang X, Xu J: Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen activated protein kinase pathway. Toxicol In Vitro 2008; 22: 1749-1753.
15. Shon YH, Park SD, Nam KS: Effective chemopreventive activity of genistein against human breast cancer cells. J Biochem Mol Biol 2006; 39: 448-451.
16. Wang C, Kurzer MS: Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 1997; 28: 236-247.
17. Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D, Ando S: Estrogen receptor α mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 2001; 60: 595-602.
18. Power KA, Thompson LU: Ligand-induced regulation of ER α and ER β is indicative of human breast cancer cell proliferation. Breast Cancer Res Treat 2003; 82: 209-221.
19. Sotoca AM, Ratman D, Saag PVD, Strom A, Gustafsson JA, Vervoort J, Rietjens IMCM, Murk AJ: Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ER α /ER β ratio. J Steroid Biochem Mol Biol 2008; 112: 171-178.
20. Chang EC, Frasor J, Komm B, Katzenellenbogen BS: Impact of estrogen receptor β on gene networks regulated by estrogen receptor in breast cancer cells. Endocrinol 2006; 147: 4831-4842.
21. Zhao C, Wright KD, Gustafsson JA: Estrogen receptor β : an overview and update. Nucl Recept Signal 2008; 6: 1621-1721.
22. Schmidt S, Michna H, Diel P: Combinatory effects of phytoestrogens and 17 β estradiol on proliferation and apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 2005; 94: 445-449.
23. Jeune MAL, Diaka JK, Brown J: Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J Med Food 2005; 8: 469-475.
24. Shaaban AM, Green AR, Karthik S, Alizadeh Y, Hughes TA, Harkins L, Ellis IO, Robertson JF, Paish EC, Saunders PT, Groome NP, Speirs V: Nuclear and cytoplasmic expression of ER β 1, ERβ2 and ERβ5 identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res 2008; 14: 5228-5235.
25. Skliris GP, Leygue E, Watson PH, Murphy LC: Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic agent. J Steroid Biochem Mol Biol 2008; 109: 1-10.